🔎 Trials Near Me

Dachaigh › Aillse sa bhlaire › Massachusetts › Boston

Sgrùdaidhean clionaigeach Aillse sa bhlaire ann an Boston, MA

Tha 26 sgrùdaidhean airson Aillse sa bhlaire a’ lorg phàirtichean aig làraichean ann agus timcheall air Boston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

A’ fastadhÌre 2
  • Massachusetts General Hospital Cancer Center, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06770582

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

A’ fastadhÌre 3
  • Brigham and Women's Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07000084

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

A’ fastadhÌre 1
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

A’ fastadhÌre 2
  • Dana-Farber Cancer Institute - Oncology Department, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06760819

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

A’ fastadhÌre 2
  • Tufts Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07061964

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

A’ fastadhÌre 1
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07090499

Patient-Centered Surgical Prehabilitation

A’ fastadhFàilte do shaor-thoilich fhallain
  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05715684

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

A’ fastadhÌre 3
  • Dana Farber Cancer Institute ( Site 0783), Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

A’ fastadhÌre 3
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07218380

Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy

A’ fastadh
  • Dana Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07548476

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

A’ fastadhÌre 1
  • Dana-Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06644755

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

A’ fastadhÌre 2
  • Brigham and Women's Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06567743

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

A’ fastadhÌre 2
  • Brigham and Women's Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

A’ fastadhÌre 1
  • Massachusetts General Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

A’ fastadhÌre 3
  • Massachusetts General Hospital Cancer Center, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07097142

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Massachusetts General Hospital Cancer Center, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

A’ fastadhÌre 1/2
  • Brigham and Women's Hospital, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT04752722

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

A’ fastadhÌre 2/3
  • Local Institution - 0195, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

A’ fastadhÌre 2
  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Aoisean 8 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05503797

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

A’ fastadhÌre 3
  • Research Site, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT07720284

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

A’ fastadhÌre 1
  • Massachusetts General Hospital, Boston
  • Brigham & Women's Hospital, Boston
  • Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
  • agus 2 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT04389632

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

A’ fastadhSgrùdadh amharc
  • Dana-Farber Cancer Institute, Boston
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 17 Gearr 2026 · NCT06138561

CONFIRM: Magnetic Resonance Guided Radiation Therapy

A’ fastadh
  • Brigham & Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Gearr 2026 · NCT04368702

Sacituzumab Govitecan Plus EV in Metastatic UC

A’ fastadhÌre 1/2
  • Dana Farber Cancer Institute, Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Samh 2025 · NCT04724018

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

A’ fastadh
  • Harvard School of Medicine/Massachusetts General Hospital (MGH), Boston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2025 · NCT04442724

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

A’ fastadhÌre 3
  • Brigham and Women's Hospital, Boston
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 28 Sult 2023 · NCT03216525

Sgrùdaidhean Aillse sa bhlaire ann am bailtean eile

Sgrùdaidhean eile ann an Boston

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.